Boston Scientific Corp

MetLife Investment Management, LLC BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

367,541

Value ($000)

35,045

Weight

0.2%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	35,045	0.2%	367,541	12/31/2025
2025 Q3	11/13/2025	37,061	0.2%	379,603	9/30/2025
2025 Q2	8/13/2025	41,728	0.2%	388,493	6/30/2025
2025 Q1	5/14/2025	38,608	0.2%	382,716	3/31/2025
2024 Q4	2/13/2025	34,836	0.2%	390,012	12/31/2024
2024 Q3	11/13/2024	32,084	0.2%	382,860	9/30/2024
2024 Q2	8/13/2024	30,197	0.2%	392,122	6/30/2024
2024 Q1	5/14/2024	23,491	0.2%	342,980	3/31/2024
2023 Q4	4/22/2024	20,547	0.1%	355,426	12/31/2023
2023 Q3	5/9/2024	19,093	0.1%	361,611	9/30/2023
2023 Q2	4/29/2024	19,736	0.1%	364,881	6/30/2023
2023 Q1	5/9/2024	18,488	0.1%	369,537	3/31/2023
2022 Q4	5/10/2024	17,303	0.1%	373,965	12/31/2022
2022 Q3	5/10/2024	14,714	0.1%	379,919	9/30/2022
2022 Q2	5/10/2024	14,352	0.1%	385,076	6/30/2022
2022 Q1	5/10/2024	17,167	0.1%	387,610	3/31/2022
2021 Q4	5/17/2024	13,374	0.1%	314,840	12/31/2021
2021 Q3	5/17/2024	13,954	0.1%	321,592	9/30/2021
2021 Q2	5/17/2024	14,087	0.1%	329,432	6/30/2021
2021 Q1	5/17/2024	13,052	0.1%	337,709	3/31/2021
2020 Q4	5/24/2024	12,502	0.1%	347,750	12/31/2020
2020 Q3	5/24/2024	13,860	0.2%	362,739	9/30/2020
2020 Q2	5/24/2024	13,119	0.1%	373,656	6/30/2020
2020 Q1	7/12/2023	11,723	0.2%	359,276	3/31/2020
2019 Q4	7/12/2023	16,744	0.2%	370,268	12/31/2019
2019 Q3	7/12/2023	15,425	0.2%	379,079	9/30/2019
2019 Q2	7/12/2023	16,475	0.2%	383,318	6/30/2019
2019 Q1	7/13/2023	15,120	0.2%	393,965	3/31/2019
2018 Q4	7/13/2023	13,985	0.2%	395,733	12/31/2018
2018 Q3	7/13/2023	15,488	0.2%	402,293	9/30/2018